Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: TECIDO ADIPOSO, ANTI-INFLAMATÓRIOS, INFLAMAÇÃO (TERAPIA), FÁRMACOS (SISTEMA CARDIOVASCULAR), ARTERIOSCLEROSE (TERAPIA)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GROSSO, Adriana Ferreira et al. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome. Diabetology and Metabolic Syndrome, v. 6, n. 47, p. (online), 2014Tradução . . Disponível em: https://doi.org/10.1186/1758-5996-6-47. Acesso em: 04 nov. 2024.APA
Grosso, A. F., Oliveira, S. F. de, Higuchi, M. de L., Favarato, D., Dallan, L. A. de O., & Luz, P. L. da. (2014). Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome. Diabetology and Metabolic Syndrome, 6( 47), (online). doi:10.1186/1758-5996-6-47NLM
Grosso AF, Oliveira SF de, Higuchi M de L, Favarato D, Dallan LA de O, Luz PL da. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome [Internet]. Diabetology and Metabolic Syndrome. 2014 ; 6( 47): (online).[citado 2024 nov. 04 ] Available from: https://doi.org/10.1186/1758-5996-6-47Vancouver
Grosso AF, Oliveira SF de, Higuchi M de L, Favarato D, Dallan LA de O, Luz PL da. Synergistic anti-inflammatory effect: simvastatin and pioglitazone reduce inflammatory markers of plasma and epicardial adipose tissue of coronary patients with metabolic syndrome [Internet]. Diabetology and Metabolic Syndrome. 2014 ; 6( 47): (online).[citado 2024 nov. 04 ] Available from: https://doi.org/10.1186/1758-5996-6-47
